The newly published report titled “Global Digital Respiratory Devices Market (Product (Sensors and Apps, Smart Inhalers and Nebulizers), Indication (Asthma and Chronic Obstructive Pulmonary Disease))– By Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2034.” of InsightAce Analytic Pvt. Ltd. features detailed industry analysis and an extensive study on the market, exploring its significant factors.
The global digital respiratory devices market is estimated to reach over USD 887.7 billion by 2034, exhibiting a CAGR of 27.8% during the forecast period.
Get A Free Report Brochure:
https://www.insightaceanalytic.com/request-sample/1377
Digital respiratory devices encompass therapeutic and diagnostic equipment integrated with smartphone applications or other data collection modules. These devices play a crucial role in monitoring and managing chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, pulmonary hypertension (PH), and other lung disorders. The rising prevalence of severe chronic respiratory diseases (CRDs) is a key driver of market growth.
The adoption of digital respiratory technology has led to significant medical benefits, including reduced hospitalizations, improved medication adherence, and fewer doctor visits. Furthermore, the COVID-19 pandemic has accelerated innovation in digital respiratory systems, further driving market demand. To enhance drug management and treatment efficiency, an increasing number of companies are incorporating digital technologies into their respiratory care products, reinforcing the industry’s growth trajectory.
List of Prominent Players in the Digital Respiratory Devices Market:
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AstraZeneca
Boehringer Ingelheim International GmbH
Capsule Technologies
Cognita Labs
Cohero Health
Findair Sp. z. o. o
GlaxoSmithKline plc
Novartis AG
Pneuma Respiratory
Propeller Health
Sensiron AG
Teva Pharmaceuticals Industries Ltd.
Market Dynamics:
Drivers-
The demand for digital respiratory devices is directly influenced by the prevalence of infectious respiratory illnesses. The COVID-19 pandemic, as the most recent and severe outbreak, has significantly increased the need for ventilators and other respiratory care equipment. This surge in demand has prompted both government and private sector initiatives to accelerate production, underscoring the critical role of respiratory treatment during health crises.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1377
Challenges:
Many patients rely on financial support to cover healthcare expenses, yet the respiratory diagnostics sector faces challenges due to inadequate reimbursement policies for diagnostic tests. Additionally, in many countries, funding for respiratory care equipment remains limited. Despite the high prevalence of major respiratory conditions such as asthma and COPD, these diseases continue to be underdiagnosed and undertreated.
Regional Trends:
North America is expected to dominate the market throughout the forecast period, driven by a large geriatric population and the increasing incidence of chronic respiratory diseases. The region benefits from well-established reimbursement policies within the U.S. healthcare system, heightened public awareness of health issues, and a robust healthcare infrastructure. Additional factors such as the rise in outpatient procedures, expanding insurance coverage, and overall economic growth further support market expansion.
The Asia-Pacific (APAC) region is anticipated to witness rapid growth due to the high prevalence of respiratory conditions, increasing healthcare expenditures, and a rapidly evolving medical infrastructure.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1377
Recent Developments:
- In February 2022, Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, launched HeroTracker® Sense, a unique digital respiratory health solution that converts a regular metered dosage inhaler (pMDI) into an intelligent linked healthcare device. HeroTracker® Sense is a metered-dose inhaler (MDI) add-on connected device that addresses patient inhalation technique and adherence.
- In September 2021, Adherium Limited, a market leader in respiratory eHealth, remote monitoring, and data management, announced that the FDA’s 510(k) approval had enabled it to begin selling its first, next-generation Hailie Sensor, which includes physiological measures for tracking the use of asthma and COPD medications.
Segmentation of Digital Respiratory Devices Market –
By Product
- Sensors and Apps
- Smart Inhalers and Nebulizers
By Indication
- Asthma
- Chronic Obstructive Pulmonary Disease
By Region-
- North America-
- US
- Canada
- Mexico
- Europe-
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Get More Information: @
https://www.insightaceanalytic.com/report/global-digital-respiratory-devices-market/1377
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
